Quantitative Systematic Strategies’s AstraZeneca AZN Stock Holding History

Quantitative Systematic Strategies’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,729	Closed	-$806K	–	47
2021 Q2	$806K	Sell	6,729 -16,159	-71%	-$1.77M	0.28%	109
2021 Q1	$2.28M	Buy	22,888 +10,718	+88%	+$1.08M	0.35%	71
2020 Q4	$1.22M	Buy	+12,170	New	+$1.29M	0.17%	194
2020 Q3	–	Sell	-22,152	Closed	-$2.34M	–	591
2020 Q2	$2.34M	Buy	22,152 +14,051	+173%	+$1.45M	0.46%	42
2020 Q1	$724K	Buy	8,101 +2,163	+36%	+$204K	0.59%	49
2019 Q4	$592K	Sell	5,938 -13,253	-69%	-$1.25M	0.09%	300
2019 Q3	$1.71M	Sell	19,191 -11,398	-37%	-$988K	0.39%	77
2019 Q2	$2.52M	Buy	30,589 +26,697	+686%	+$2.09M	0.48%	61
2019 Q1	$315K	Buy	+3,892	New	+$307K	0.08%	250
2018 Q4	–	Sell	-9,158	Closed	-$725K	–	696
2018 Q3	$725K	Sell	9,158 -15,155	-62%	-$1.15M	0.14%	240
2018 Q2	$1.71M	Buy	24,313 +2,999	+14%	+$216K	0.31%	81
2018 Q1	$1.49M	Sell	21,314 -3,981	-16%	-$276K	0.32%	89
2017 Q4	$1.75M	Sell	25,295 -1,729	-6%	-$117K	0.45%	49
2017 Q3	$1.83M	Buy	27,024 +23,729	+720%	+$1.5M	0.48%	56
2017 Q2	$225K	Sell	3,295 -8,113	-71%	-$530K	0.06%	370
2017 Q1	$710K	Buy	+11,408	New	+$664K	0.2%	166

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Quantitative Systematic Strategies's AZN Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of AstraZeneca (AZN) in Q3 2021, closing a stake of 6,729 shares — an estimated $806K sold.

Quantitative Systematic Strategies first reported a position in AZN in Q1 2017 and held it in 16 quarters. The position peaked at $2.52M in Q2 2019. 905 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

Quantitative Systematic Strategies reported no remaining AstraZeneca position as of Q3 2021 after selling out during the quarter.
Quantitative Systematic Strategies sold 6,729 AstraZeneca shares in Q3 2021, an estimated $806K.
Quantitative Systematic Strategies first reported a position in AstraZeneca in Q1 2017 and held it in 16 quarters.
Quantitative Systematic Strategies's AstraZeneca position peaked at $2.52M in Q2 2019.
905 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.